DEA Schedule CIII
Strength
2 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858050103
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Last Updated
4/22/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207276On Market Since
10/25/2017
Pharmacological Classes
Partial Opioid Agonist
Partial Opioid Agonists
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
BUPRENORPHINE 2 MG TABLET SL
Generic
00054017613•Hikma Pharmaceuticals USA Inc.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00121101930•PAI Holdings LLC
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00228315603•Actavis Pharma, Inc.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00904715404•Major Pharmaceuticals
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
50268012815•AvPAK
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
60687048121•American Health Packaging
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
62756045983•Sun Pharmaceutical Industries Inc.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
72888018230•Advagen Pharma Ltd.
$0.2676
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00054018813•Hikma Pharmaceuticals USA Inc.
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00121101830•PAI Holdings LLC
$0.4698
per EA